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What makes research involving human
subjects ethical?





Informed consent is necessary (in most cases) but not
sufficient
Other issues: clinical research in developing
countries, use of placebos, phase 1 research,
protection for communities, involvement of children

A systematic framework is proposed to
evaluate clinical studies
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Social or Scientific Value
Scientific Validity
Fair Subject Selection
Favorable Risk-Benefit Ratio
Independent Review
Informed Consent
Respect for Potential and Enrolled Subjects



To be valuable, research should






Why?





evaluate an intervention that could lead to
improvements in health or well-being
be a preliminary study to such research
Lead to general knowledge about structure/function
of human biological systems
Responsible use of finite resources
Avoidance of exploitation

Consider comparing the relative value of
different clinical research studies



“Scientifically unsound research on human subjects is
ipso facto unethical in that it may expose subjects to
risks or inconvenience to no purpose.”
 International Ethical Guidelines for Biomedical Research involving
Human Subjects – CIOMS, 1993.






Research should have a clear scientific objective, be
designed using accepted principles, methods and
reliable practices, have sufficient power, offer plausible
data analysis plan
Must have honest null hypothesis, “clinical equipoise”
Why?



Responsible use of finite resources
Avoidance of exploitation



Scientific goals of the study should be primary
basis for determining who will be enrolled








Groups should not be excluded without good reason

Recognize that subject selection can affect the
risks and benefits of the study
Groups/individuals who bear the risks of
research should be able to enjoy its benefits
Why?


Equals should be treated similarly, benefits/burdens
should be distributed evenly



Assessment of potential risks


Risks to individual subjects are identified and minimized
 Procedures which are consistent with sound research design
 Using procedures already being performed on the subjects

for diagnostic/treatment purposes



Potential benefits to individual subjects are enhanced

 Should be consistent with the scientific objectives, tests and

interventions
 Extraneous benefits (e.g. payment, more unrelated health
services) should not be weighed against the risks



Risks and benefits to individual subjects are compared

 The more likely/serious the potential risks are, the greater

the prospective benefits should be



What if no clinical benefit to subjects (e.g. Phase I
trial)?
“risk-knowledge calculus”*: when do benefits to society
outweigh risks to individuals
 No stable framework
 Utilitarian approach controversial


 *Weijer C. Thinking clearly about research risk: implications of the work of Benjamin
Freedman. IRB. 1999 Nov-Dec;21(6):1-5.



Why?


Beneficence



Nonmaleficence

 Need to enhance benefits
 Need to avoid the exploitation of subjects
 Need to reasonably reduce the risks






Minimize the potential impacts of conflicts of
interest (e.g. to conduct high-quality research,
complete the research expeditiously, protect
research subjects, obtain funding, advance
career)
Social accountability
Who?




Granting agencies
Local IRBs
Data and safety monitoring board



Purpose:

To ensure that individuals control whether or not they
participate
 To ensure that individuals participate only when research
is consistent with values/interests/preferences.




To provide informed consent:

Must be accurately informed of details
Understand this information and how it relates to their
situation
 Make a voluntary and uncoerced decision about whether
to participate





Non-autonomous persons should be respected



Substituted judgement
Best interests










Respect privacy by managing information in
accordance with confidentiality rules
Subjects should be permitted to change their
mind and withdraw without penalty
Enrolled subjects should be provided with new
information regarding the intervention should
it become available
Welfare of subjects should be monitored.
Study subjects should be informed about what
was learned from the research
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